-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
Black Immunotherapy History: Black Leaders in Cancer and Immunology
This Black History Month, meet a few Black leaders who have contributed to our understanding of the…
-
The Future Is Now: Honoring Scientists and Philanthropists Who Lay the Foundation for New Cancer Treatments
Actor and comedian Joel McHale hosted the first-ever CRI Virtual Awards Gala honoring YouTuber and philanthropist Markiplier,…
-
Cancer Patients Gain Knowledge, Take Action
As a stage 4 metastatic breast cancer patient, Chawnté was eager to find immunotherapy clinical trial options.
-
Defining Resistance to Treatment with Anti-PD-1/PD-L1 Immunotherapy
CRI's Vanessa M. Lucey, Ph.D, MBA, helps guide the design and analysis of future clinical trials involving…
